Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Chris Lavy has been nominated as a Hospital Hero by cyclist who he operated on. The grateful patient, Professor Lee Sweetlove, has raised money for a charity Professor Lavy is involved in by cycling through the Dolomites as well as nominating him for the award.

Professor Chris Lavy has been nominated for the Hospital Heroes awards, which celebrate the outstanding achievements of both individuals and teams, whether they are working directly with patients or behind the scenes. Also a surgeon at the Nuffield Orthopaedic Centre, Professor Lavy operated on Professor Lee Sweetlove, an Oxford University professor of plant sciences and keen mountain biker who broke his back in two places in a cycling accident in 2010. Professor Sweetlove made a full recovery and is now nominating the surgeon who made it possible.

Professor Lavy said that he was "overwhelmed" to be nominated and added: "It is the most brilliant thing to see someone who is injured and can hardly move through some surgery and to get them walking again."

As a thank-you, last September Professor Sweetlove cycled 16 mountain passes with two friends over about 250 miles in the Italian Dolomites in five days to raise £2,880 for a charity set up by Prof Lavy. Beit CURE International Hospital sees more than 20,000 children a year for conditions like clubfoot in Malawi, Africa, where Prof Lavy worked for a decade.

Prof Sweetlove said: "He really went above and beyond the call of duty. Leading up to the original surgery I saw numerous doctors and he was the first to show complete control of what he was doing and also real human compassion."

With a risk of paralysis from the surgery, he said the doctor's manner was key, adding: "He knew what I was going through."

Similar stories

New Associate Professors announced at NDORMS

The Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS.

COVID-19 vaccines shown to reduce infection by 90% in nursing homes

A new collaborative study between the Catalan Institute of Health, the Public Health Secreatariat of Catalonia, and the Centre for Statistics in Medicine, NDORMS, at the University of Oxford have confirmed that COVID-19 vaccines greatly reduce infections, hospitalisations and mortality for up to 6 months.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Unlocking the secrets of the microbiome

Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.

Into the future: watching biology unfold

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.

New Botnar Research Institute Director starts today

Professor Jonathan Rees begins his new role as Director of the Botnar Research Institute today, taking over from Professor Andrew Carr.